JPMORGAN CHASE & CO - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 73 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69
-41.5%
940.0%0.00%
Q2 2023$118940.0%0.00%
Q1 2023$0940.0%0.00%
Q4 2022$0940.0%0.00%
Q3 2022$0940.0%0.00%
Q2 2022$0
-100.0%
94
-99.8%
0.00%
Q1 2022$69,0000.0%54,960
+27.0%
0.00%
Q4 2021$69,000
-72.8%
43,277
-44.6%
0.00%
Q3 2021$254,000
-74.3%
78,074
-50.1%
0.00%
Q2 2021$988,000
+4390.9%
156,324
+1276.8%
0.00%
Q3 2019$22,00011,3540.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 362,072$453,0000.07%
GSA CAPITAL PARTNERS LLP 66,223$83,0000.01%
Aquatic Capital Management LLC 4,400$6,0000.01%
D. E. Shaw & Co., Inc. 3,863,135$4,829,0000.01%
Spire Wealth Management 94,000$118,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 111,898$140,0000.00%
Renaissance Technologies 2,100,492$2,626,0000.00%
ALPS ADVISORS INC 130,141$163,0000.00%
Cutler Group LLC / CA 21,400$30,0000.00%
TWO SIGMA ADVISERS, LP 681,600$852,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders